Providing support and services for people and families living with ALS in Ontario.
Funding high-quality research that offers the most promise to slow down ALS or even stop it.
Advocating for policy that will have a meaningful impact on people living with ALS today and in the future.
Many individuals and organizations generously give their time to create and host fundraising even...
Meet the researchers behind the winning 2022 Discovery Grant projects Could protecting the axon represent a promising treatment strategy for ALS? Award: $300,000 Collaborators: Dr. Gary Armstrong, McGill University Dr. Alex Parker, at the Centre de recherche du CHUM, Université...
August 1, 2023 - The province of Ontario has listed RADICAVA Oral Suspension (edaravone), also known as oral edaravone, on the public formulary as a therapy accessible through the Ontario...
Read the update